DecImmune Therapeutics, Inc. develops novel peptides and antibodies for acute tissue damaging inflammation in myocardial infarction, burns, vascular.
Business Model:
Revenue: $29.5M
Employees: 51-200
Address: 55 Cambridge Pkwy
City: Cambridge
State: MA
Zip: 02142
Country: US
DecImmune Therapeutics, Inc. develops novel peptides and antibodies for acute tissue damaging inflammation in myocardial infarction, burns, vascular.
Contact Phone:
+16172786655
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2013 | Venture Round | 3 | $2.3M |
Astellas Venture Management Broadview Ventures HealthCare Ventures Astellas Venture Management Broadview Ventures HealthCare Ventures |
9/2010 | Venture Round | 3 | $3.2M |
Amgen Ventures Astellas Venture Management HealthCare Ventures Amgen Ventures Astellas Venture Management HealthCare Ventures |
10/2014 | Grant | $3M | 9/2010 | Unattributed | $3M |
Astellas Venture Management HealthCare Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|